Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas
- PMID: 14991897
- DOI: 10.1002/path.1524
Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas
Abstract
The effects of selenium, an essential nutrient with anti-carcinogenic properties, are mediated by selenium-binding proteins. The protein expression status of human selenium-binding protein 1 (SBP1) in human tumours and the exact function of this protein are not known. In this study, quantitative two-dimensional polyacrylamide gel electrophoresis (2-D PAGE) was used on 93 lung adenocarcinomas and ten uninvolved lung samples. Two likely isoforms of a 56 kD protein that showed a significantly decreased abundance in lung adenocarcinomas were observed. Tandem mass spectrometry and 2-D western blot analysis identified these two proteins as human SBP1. Tumour tissue microarrays were utilized to examine the cellular expression patterns of SBP1 using immunohistochemistry. The same tissue samples were examined for SBP1 mRNA expression using oligonucleotide microarrays. Two major SBP1 isoforms were detected, with an acidic isoform (457) being significantly down-regulated in lung adenocarcinomas compared with normal lung (p = 0.02). Two additional more acidic SBP1 isoforms were only observed in normal lung. SBP1 protein isoforms and SBP1 mRNA levels were significantly decreased in poorly differentiated (versus moderately and well-differentiated), T2-T4 (versus T1), and bronchus-derived (versus bronchioloalveolar) tumours. Low levels of SBP1 protein (native form, 460) correlated significantly with poor survival (p = 0.007). The lack of SBP1 expression was not due to gene deletion. Treatment of A549 lung adenocarcinoma cells with the methylation inhibitor 5-azacytidine did not affect expression of the SBP1 protein. Analysis of the tumour proliferation status using Ki-67 suggests that down-regulated expression of SBP1 may reflect increased cell proliferation and decreased differentiation in lung adenocarcinomas.
Copyright 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Similar articles
-
Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas.Oncogene. 2003 Sep 11;22(39):7950-7. doi: 10.1038/sj.onc.1206529. Oncogene. 2003. PMID: 12970743
-
Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas.Clin Lung Cancer. 2004 Mar;5(5):307-12. doi: 10.3816/CLC.2004.n.011. Clin Lung Cancer. 2004. PMID: 15086970
-
Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.Mol Nutr Food Res. 2008 Nov;52(11):1289-99. doi: 10.1002/mnfr.200700331. Mol Nutr Food Res. 2008. PMID: 18435490
-
Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis.J Pathol. 2003 Aug;200(5):640-6. doi: 10.1002/path.1378. J Pathol. 2003. PMID: 12898601
-
Selenium-Binding Protein 1 in Human Health and Disease.Int J Mol Sci. 2018 Nov 2;19(11):3437. doi: 10.3390/ijms19113437. Int J Mol Sci. 2018. PMID: 30400135 Free PMC article. Review.
Cited by
-
Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.J Transl Med. 2020 Jan 9;18(1):17. doi: 10.1186/s12967-020-02211-4. J Transl Med. 2020. PMID: 31918717 Free PMC article.
-
Loss of aquaporin-4 expression and putative function in non-small cell lung cancer.BMC Cancer. 2011 May 6;11:161. doi: 10.1186/1471-2407-11-161. BMC Cancer. 2011. PMID: 21548930 Free PMC article.
-
Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.Mol Cancer Res. 2018 Nov;16(11):1737-1749. doi: 10.1158/1541-7786.MCR-18-0392. Epub 2018 Jul 12. Mol Cancer Res. 2018. PMID: 30002193 Free PMC article.
-
Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer.Elife. 2022 Oct 25;11:e80150. doi: 10.7554/eLife.80150. Elife. 2022. PMID: 36282174 Free PMC article.
-
Evidence that selenium binding protein 1 is a tumor suppressor in prostate cancer.PLoS One. 2015 May 18;10(5):e0127295. doi: 10.1371/journal.pone.0127295. eCollection 2015. PLoS One. 2015. PMID: 25993660 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials